Sign In
Buy KNBIF
$0.0202
+0 (+0%)
At Close: Jul 31, 2026
Kane Biotech launches 2021 business update series
10:00am, Wednesday, 16'th Jun 2021
Premiere episode “The Fundamentals” available now Premiere episode “The Fundamentals” available now
Kane Biotech Announces Adoption of Performance and Restricted Share Unit Plan and Amended and Restated Stock Option Plan
04:00pm, Wednesday, 09'th Jun 2021
WINNIPEG, Manitoba, June 09, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announced that, at the annual and special meeting of
Kane Biotech to Release First Quarter 2021 Financial Results on May 27 – Conference Call to Follow
08:00am, Thursday, 20'th May 2021
WINNIPEG, Manitoba, May 20, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development
Kane Biotech Announces Fourth Quarter and Full Year 2020 Financial Results
04:00pm, Thursday, 25'th Mar 2021
WINNIPEG, Manitoba, March 25, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, developme
Kane Biotech to Release Fourth Quarter and Full Year 2020 Financial Results on March 25 – Conference Call to Follow
04:30pm, Thursday, 18'th Mar 2021
WINNIPEG, Manitoba, March 18, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, developme
Kane Biotech Announces Positive Efficacy Results in STEM Pet Oral Care Clinical Trial
08:00am, Wednesday, 10'th Mar 2021
WINNIPEG, Manitoba, March 10, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane”), announced today that preliminary analysis of data from efficacy tr
Kane Biotech Announces New Chairman
08:45am, Wednesday, 24'th Feb 2021
WINNIPEG, Manitoba, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), announced today current Board member Mark Nawacki will take
Kane Biotech Announces Launch of New Human Health OTC DermaKB™ Product Line
08:30am, Thursday, 10'th Dec 2020
WINNIPEG, Manitoba, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, developmen
Kane Biotech Announces Third Quarter 2020 Financial Results
05:31pm, Thursday, 26'th Nov 2020
WINNIPEG, Manitoba, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, developmen
